Drug Shortage Report for TOBI

Last updated on 2024-04-16 History
Report ID 192953
Drug Identification Number 02239630
Brand name TOBI
Common or Proper name TOBRAMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 56 AMPULES
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-06-01
Actual start date 2023-05-31
Estimated end date 2024-04-30
Actual end date
Shortage status Actual shortage
Updated date 2024-04-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2024-04-16 French Compare
v34 2024-04-16 English Compare
v33 2024-03-25 French Compare
v32 2024-03-25 English Compare
v31 2024-03-12 French Compare
v30 2024-03-12 English Compare
v29 2024-02-21 French Compare
v28 2024-02-21 English Compare
v27 2024-02-15 French Compare
v26 2024-02-15 English Compare
v25 2024-01-22 French Compare
v24 2024-01-22 English Compare
v23 2023-12-19 French Compare
v22 2023-12-19 English Compare
v21 2023-12-12 French Compare
v20 2023-12-12 English Compare
v19 2023-11-06 French Compare
v18 2023-11-06 English Compare
v17 2023-10-17 French Compare
v16 2023-10-17 English Compare

Showing 1 to 20 of 35